SHH and non-small cell lung carcinoma: Furthermore, CD133+ NSCLC cells also exhibit CSC properties and secrete SHH ligand, and HH pathway inhibition in CD133+ cells attenuated sphere formation, suggesting that the autocrine HH pathway is involved in CD133+ CSC maintenance [87].